| | english | español | français |
Go to record ID
  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
115659
Status
Published
Date of creation
2020-06-16 10:11 UTC (jnjagi@biosafetykenya.go.ke)
Date of publication
2020-07-21 11:31 UTC (mutui@biosafetykenya.go.ke)

General Information
Country
  • Kenya
Title of risk assessment
Summary risk assessment report on the application for Confined Field Trial of a novel Rift Valley Fever Vaccine in sheep, goats, cattle and camels  
Date of the risk assessment
2016-11-25
Competent National Authority(ies) responsible for the risk assessment
National Biosafety Authority
Pest Control Products Board (PCPB) Building, Loresho, off Waiyaki Way
Nairobi, Nairobi
Kenya, 28251--00100
Phone:(+254) (20) (2678667)
Email:info@biosafetykenya.go.ke
Url:National Biosafety Office - Kenya
Risk assessment details
Living modified organism
Rift Valley Fever Virus DIVA vaccine
Dr. George Warimwe Production of medical or pharmaceutical compounds (human or animal) - Vaccines, Antibodies and antigens
Scope of the risk assessment
Risk assessment report / Summary

   
   
Rate this page  - 65 people have rated this page  
United Nations Environment Programme United Nations